Crossmark

A novel 5-differentially expressed gene (DEG) signature predicting the prognosis in patients with metastatic liver malignancies and the prognostic and therapeutic potential of SPP1

Crossref DOI link: https://doi.org/10.1007/s10147-025-02723-3

Published Online: 2025-02-27

Published Print: 2025-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Jing

Yu, Zijian

Liu, Qiong

Dou, Chengyun

Cao, Peng

Xie, Xia
Funding

Funding for this research was provided by:

Health Commission of Hunan Province (202103080306)

Natural Science Foundation of Hunan Province (2022JJ40398)
License Information

Text and Data Mining valid from 2025-02-27

Version of Record valid from 2025-02-27
More Information

Article History

Received: 4 June 2024

Accepted: 4 February 2025

First Online: 27 February 2025

Declarations

:

: The authors declare no competing interest.

: All procedures performed were in accordance with the ethical standards granted by the First Affiliated Hospital, Hengyang Medical School, University of South China.

: All authors agree to publication.

Document is current

Any future updates will be listed below